chr9-34500881-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_012144.4(DNAI1):c.1019+42C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.207 in 1,480,920 control chromosomes in the GnomAD database, including 34,461 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.16 ( 2524 hom., cov: 32)
Exomes 𝑓: 0.21 ( 31937 hom. )
Consequence
DNAI1
NM_012144.4 intron
NM_012144.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0480
Genes affected
DNAI1 (HGNC:2954): (dynein axonemal intermediate chain 1) This gene encodes a member of the dynein intermediate chain family. The encoded protein is part of the dynein complex in respiratory cilia. The inner- and outer-arm dyneins, which bridge between the doublet microtubules in axonemes, are the force-generating proteins responsible for the sliding movement in axonemes. The intermediate and light chains, thought to form the base of the dynein arm, help mediate attachment and may also participate in regulating dynein activity. Mutations in this gene result in abnormal ciliary ultrastructure and function associated with primary ciliary dyskinesia and Kartagener syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 9-34500881-C-T is Benign according to our data. Variant chr9-34500881-C-T is described in ClinVar as [Benign]. Clinvar id is 260194.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.352 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAI1 | NM_012144.4 | c.1019+42C>T | intron_variant | Intron 11 of 19 | ENST00000242317.9 | NP_036276.1 | ||
DNAI1 | NM_001281428.2 | c.1031+42C>T | intron_variant | Intron 11 of 19 | NP_001268357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAI1 | ENST00000242317.9 | c.1019+42C>T | intron_variant | Intron 11 of 19 | 1 | NM_012144.4 | ENSP00000242317.4 | |||
DNAI1 | ENST00000614641.4 | c.1031+42C>T | intron_variant | Intron 11 of 19 | 5 | ENSP00000480538.1 |
Frequencies
GnomAD3 genomes AF: 0.162 AC: 24709AN: 152084Hom.: 2523 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
24709
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.198 AC: 49513AN: 250246 AF XY: 0.207 show subpopulations
GnomAD2 exomes
AF:
AC:
49513
AN:
250246
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.212 AC: 282023AN: 1328718Hom.: 31937 Cov.: 21 AF XY: 0.215 AC XY: 143572AN XY: 668244 show subpopulations
GnomAD4 exome
AF:
AC:
282023
AN:
1328718
Hom.:
Cov.:
21
AF XY:
AC XY:
143572
AN XY:
668244
Gnomad4 AFR exome
AF:
AC:
1321
AN:
30482
Gnomad4 AMR exome
AF:
AC:
4033
AN:
44552
Gnomad4 ASJ exome
AF:
AC:
3913
AN:
25284
Gnomad4 EAS exome
AF:
AC:
14419
AN:
39132
Gnomad4 SAS exome
AF:
AC:
22876
AN:
83478
Gnomad4 FIN exome
AF:
AC:
9271
AN:
53166
Gnomad4 NFE exome
AF:
AC:
214221
AN:
991706
Gnomad4 Remaining exome
AF:
AC:
11103
AN:
55996
Heterozygous variant carriers
0
12248
24495
36743
48990
61238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
7066
14132
21198
28264
35330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.162 AC: 24718AN: 152202Hom.: 2524 Cov.: 32 AF XY: 0.163 AC XY: 12097AN XY: 74406 show subpopulations
GnomAD4 genome
AF:
AC:
24718
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
12097
AN XY:
74406
Gnomad4 AFR
AF:
AC:
0.0497424
AN:
0.0497424
Gnomad4 AMR
AF:
AC:
0.125605
AN:
0.125605
Gnomad4 ASJ
AF:
AC:
0.153691
AN:
0.153691
Gnomad4 EAS
AF:
AC:
0.36566
AN:
0.36566
Gnomad4 SAS
AF:
AC:
0.277893
AN:
0.277893
Gnomad4 FIN
AF:
AC:
0.177797
AN:
0.177797
Gnomad4 NFE
AF:
AC:
0.213683
AN:
0.213683
Gnomad4 OTH
AF:
AC:
0.171402
AN:
0.171402
Heterozygous variant carriers
0
1018
2036
3055
4073
5091
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1029
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Apr 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Kartagener syndrome Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at